Biparatopic antibodies binding to two different epitopes of tumor necrosis factor receptor 2 (TNFR2) are developed, and one of them binds TNFR2 in a 1:1 manner, functions as an antagonist without transducing intracellular signal.
- Hiroki Akiba
- Junso Fujita
- Kouhei Tsumoto